HansBiomed Corporation (KOSDAQ:042520)
South Korea · Delayed Price · Currency is KRW 25,750
+2,150 (9.11%)
At close: Jun 11, 2026
HansBiomed Market Cap
HansBiomed has a market cap or net worth of 362.24 billion as of June 12, 2026. Its market cap has increased by 260.37% in one year.
Market Cap
362.24B
Enterprise Value
386.27B
Revenue
110.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
25,750.00
Market Cap Chart
Since October 9, 2009, HansBiomed's market cap has increased from 49.00B to 362.24B, an increase of 639.19%. That is a compound annual growth rate of 12.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 362.24B | -4.11% |
| Dec 30, 2025 | 377.76B | 229.79% |
| Dec 30, 2024 | 114.55B | -39.92% |
| Dec 28, 2023 | 190.65B | 100.91% |
| Dec 29, 2022 | 94.89B | -16.49% |
| Dec 30, 2021 | 113.63B | -16.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 582.21B |
| Curocell | 430.13B |
| IMBiologics | 393.05B |
| S.Biomedics | 380.84B |
| IntoCell | 356.02B |
| Genome & Company | 259.75B |
| Kanaph Therapeutics | 249.42B |
| curacle co.,ltd. | 240.10B |